INVENRA'S BISPECIFIC PIPELINE 

Program
Discovery
Lead Selection
Preclinical
Phase I
T-Cell Redirecting B-Bodies
INV531 (OX40 Agonist)
 INV321 (Treg Depleter SNIPER™)
 INV721 (Tumor SNIPER™)
Exelixis B-Body discovery collaboration (undisclosed)

Invenra®

505 South Rosa Road; Suite 235, Madison, WI 53719       info@invenra.com  |   608.441.8319

connect with us
  • Twitter - Black Circle
  • LinkedIn - Black Circle

© 2018 Invenra, Inc. All Rights Reserved.